• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Hanmi Pharmaceutical - Articles and news items

Hanmi and Janssen sign agreement to develop HM12525A

Industry news / 11 November 2015 / Victoria White

HM12525A is a novel biologic GLP-1/Glucagon dual receptor agonist to treat diabetes and obesity…

Sanofi and Hanmi announce diabetes license agreement

Industry news / 5 November 2015 / Victoria White

Sanofi and Hanmi have entered a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments…


Boehringer Ingelheim obtains exclusive rights to HM61713

Industry news / 28 July 2015 / Victoria White

Boehringer Ingelheim has entered an exclusive and collaboration agreement for the development and global commercialisation rights of HM61713…